Assistant Professor, Medicine, University of Washington School of Medicine
Hematology
Dr. Andrei R. Shustov, MD
|
|
Give Review
Andrei Shustov practices Hematology. He graduated from Crimea State Medical University. Andrei Shustov is also published. He has 41 publications published. The lastest publication: "Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuc...' Doctor Andrei R. Shustov, MD accepts all Medicare patients.
Publications
- Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell Lymphoma.
- Targeting B cell receptor signaling with ibrutinib in diffuse large B cell Lymphoma.
- Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30+ Peripheral T-Cell Lymphomas: Results of a Phase I Study.
- Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin Lymphoma patients can increase the proportion achieving FDG PET negative status.
- Autologous transplant for relapsed follicular Lymphoma: impact of pre-transplant rituximab sensitivity.
- Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive Lymphomas: a retrospective evaluation of safety and efficacy.
- Central Nervous System Involvement in Cutaneous T-Cell Lymphoma: 2 Illustrative Cases and a Review of Current Literature.
- Specific Features Identify Patients with Relapsed or Refractory Mantle Cell Lymphoma Benefitting from Autologous Hematopoietic Cell Transplantation.
- Hepatosplenic T-cell Lymphoma: is cure possible?
- A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide (ICE) in patients with relapsed Lymphoma.
- Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study.
- Clinical Binding Properties, Internalization Kinetics, and Clinicopathologic Activity of Brentuximab Vedotin: An Antibody-Drug Conjugate for CD30-Positive Lymphoid Neo...
- Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy.
- Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory Acute myeloid leukaemia.
- In-vivo purging of the circulating clonal T-Cells with Alemtuzumab prior to autologous peripheral blood hematopoietic Cell mobilization and transplantation.
- Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving Hig...
- Histology and Time to Progression Predict Survival for Lymphoma Recurring after Reduced-Intensity Conditioning and Allogeneic Hematopoietic Cell Transplantation.
- Pralatrexate in patients with relapsed or refractory peripheral T-cell Lymphoma: results from the pivotal PROPEL study.
- Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory Lymphoma: a prospective multi-center phase II study ...
- Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell Lymphomas.
- A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic Leukemia.
- Fas expression on antigen-specific T Cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T Cell responses but not for T Cell-dependent...
- T-cell Lymphoma: one name with a dozen faces.
- Evidence-based guidelines--an introduction.
- Does high-dose therapy and autologous hematopoietic stem cell transplantation have a role in the primary treatment of peripheral T-cell Lymphomas? ASH evidence-based r...
- In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL.
- Role of perforin in controlling B-Cell hyperactivity and humoral autoimmunity.
- Differential expression of Fas and Fas ligand in Acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and I...
- Heterogeneity of platelet aggregation and major surface receptor expression in patients with Acute myocardial infarction.
- Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of Acute myocardial infarction treatment. GUSTO-III ...
- Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with Acute myocardial infarction as predictors of unsuc...
- Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for Acute myocardial infarction. GUSTO-III Investigators.
- A major role for the Fas pathway in Acute graft-versus-host disease.
- Changes in the haemostatic profile during magnesium deficiency in swine.
- Romidepsin for the treatment of relapsed/refractory peripheral T-cell Lymphoma: pivotal study update demonstrates durable responses.
- Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.
- Pretransplant minimal residual disease predicts survival in mantle cell Lymphoma patients undergoing autologous stem cell transplantation in complete remission.
- A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral...
- A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell Lymphoma (DLBCL).
- Kikuchi-Fujimoto Disease Associated With Subcutaneous Panniculitis-Like T-Cell Lymphoma.
Schools
Crimean State Medical Institute
York Hospital
University MD
University Wa
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Washington -
Wellspan York Hospital -
Crimea State Medical University
Hospital
-
Seattle Children's Hospital -
University of Washington Medical Center
Drug Facts
| NPI NUMBER | 1346247632 | |
| NPPES Provider LastName | SHUSTOV | |
| NPPES Provider FirstName | ANDREI | |
| NPPES Provider ZIPCode | 981091023 | |
| NPPES Provider State | WA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 78.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1346247632 |
| Last Name Of The Provider | SHUSTOV |
| First Name Of The Provider | ANDREI |
| View All |
Similar Doctors
|
|
Dr. David G. Maloney, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anthony L. Back, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Craig R. Nichols, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheldon Z. Goldberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Garcia, MD |
|
|
Dr. Sandra D. Bohling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristine C. Doney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allison J. Shaw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel B. Salit, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven Kussick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack W. Singer, MD |
|
|
Dr. Paul V. O'Donnell, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Toni K. Roberts, MD |
|
|
Dr. Terry B. Gernsheimer, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Charles M. Bagley Jr., MD |
|
|
Dr. Hesham M. Eissa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tejaswini M. Dhawale, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William E. Hobbs II, MD |
|
|
Dr. Niranjan N. Rathod, MD |
|
|
Dr. Roland B. Walter, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Stefanie Buchholz |